Cardiovascular risk in patients with hemophilia

Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden

(2013) S. Lövdahl et al.   HAEMOPHILIA

Prevalence and Risk Factors for Hypertension in Hemophilia

(2013) Annette von Drygalski et al.   HYPERTENSION

Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner

(2013) Julian I. Borissoff et al.   PLoS One

HIV Infection and the Risk of Acute Myocardial Infarction

(2013) Matthew S. Freiberg et al.   JAMA Internal Medicine

The Beneficial Effects of a Direct Thrombin Inhibitor, Dabigatran Etexilate, on the Development and Stability of Atherosclerotic Lesions in Apolipoprotein E-deficient Mice

(2012) Nikolaos P. E. Kadoglou et al.   CARDIOVASCULAR DRUGS AND THERAPY

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Coronary Artery Calcification in Hemophilia A

(2011) Attie Tuinenburg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US)

(2011) A. A. SHARATHKUMAR et al.   HAEMOPHILIA

Novel insights into the development of atherosclerosis in hemophilia A mouse models

(2011) D. R. FABRI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Coronary artery calcification score and carotid intima-media thickness in patients with hemophilia

(2011) M. ZWIERS et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Factor VIII deficiency does not protect against atherosclerosis

(2011) S. BIERE-RAFI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The Hemostatic System as a Modulator of Atherosclerosis

(2011) Julian Ilcheff Borissoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-fatal cardiovascular disease, malignancies, and other co-morbidity in adult haemophilia patients

(2011) Dietje E. Fransen van de Putte et al.   THROMBOSIS RESEARCH

Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors

(2010) A. Mostafa et al.   GUT

Cardiovascular risk assessment in haemophilia patients

(2010) Manuel Baarslag et al.   THROMBOSIS AND HAEMOSTASIS

How I treat age-related morbidities in elderly persons with hemophilia

(2009) P. M. Mannucci et al.   BLOOD

Hypercoagulability Inhibits Monocyte Transendothelial Migration Through Protease-Activated Receptor-1-, Phospholipase-Cβ-, Phosphoinositide 3-Kinase-, and Nitric Oxide-Dependent Signaling in Monocytes and Promotes Plaque Stability

(2009) Stefanie Seehaus et al.   CIRCULATION

Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline

(2009) R. E. G. SCHUTGENS et al.   HAEMOPHILIA

ACCF/AHA 2009 Performance Measures for Primary Prevention of Cardiovascular Disease in Adults

(2009) Rita F. Redberg et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Von Willebrand Factor in Cardiovascular Disease

(2008) Alexander O. Spiel et al.   CIRCULATION

Endothelial dysfunction in haemophilia patients

(2008) M. T. SARTORI et al.   HAEMOPHILIA